$PPHM Reports 3Q loss

Biotech Stocks

Peregrine reports 3Q loss

Peregrine posts third-quarter loss of $13 million
TUSTIN, Calif. (AP) _ Peregrine Pharmaceuticals Inc. (PPHM) on Thursday reported a loss of $13 million in its fiscal third quarter.

On a per-share basis, the Tustin, California-based company said it had a loss of 8 cents.

The pharmaceutical posted revenue of $5.7 million in the period.

In the final minutes of trading on Thursday, the company’s shares hit $1.45. A year ago, they were trading at $2.33.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PPHM at http://www.zacks.com/ap/PPHM


Please enter your comment!
Please enter your name here